VETERINARY SERVICES

View More

PHARMACY SERVICES

View More

Welcome to RamanPharma!

Raman Pharma is a UK based MHRA and VMD Licensed Wholesaler supplying to the Human and Veterinary Market. We are a family run company ambitiously changing the face of the Pharmaceutical and Veterinary Market alike in order to serve the needs of our customers and their patients.

Our Philosophy and business are structured around the requirements of our customers and we are committed to giving them our upmost attention and care. We believe in delivering quality and value to our customers wherever they may be.


Our UK and Ireland Products

The Herbal Horse and Pet is a South African manufacturer of a very innovative range of supplements for horses, dogs and cats. Their philosophy of using a large number of different ingredients in small amounts mimics nature in that the healing effect of the ingredients is maximised while undesirable side-effects are minimised. These unique formulations, in conjunction with 21st century scientific research and techniques are what they call “cutting edge nature”.

They are manufactured in a GMP Compliant Factory and has a large following from riders and pet owners across the world. Please follow the link to the website – www.theherbalhorse.co.uk to see all the amazing blogs and the ability to purchase these products online. The Equine and Pet Range were introduced to the UK Market in September 2014 by Raman Pharma to give the UK a taste of the future in equine and companion animal nutritional supplements.


Testimonials


Pharmacy News
  • Class 2 Medicines recall: Ranitidine Effervescent Tablets 150mg and 300mg
    Thursday, October 17, 2019 2:32 pm

    Class 2 MHRA medicines recall – Ranitidine Effervescent Tablets 150mg and 300mg (Teva UK Limited trading as ratiopharm GmbH) Drug alert number: EL (19)A/27 Date issued: 17 October 2019 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 2 medicines recall for: Ranitidine Effervescent Tablets 150mg and 300mg (Teva UK Limited trading...

  • Further medicines added to the list of medicines that cannot be parallel exported from the UK
    Thursday, October 17, 2019 12:50 pm

    Further to our news story Temporary parallel export ban issued to ensure continued supply of medicines the Department of Health and Social Care (DHSC) and the Medicines and Healthcare products Regulatory Agency (MHRA) has announced that a further four medicines are to be added to the list of medicines which must not be parallel exported...

  • PQS: Support available for the dementia-friendly environment checklist and action plan
    Thursday, October 17, 2019 11:34 am

    Community pharmacy contractors may now like to consider completing the dementia-friendly environment checklist and action plan to meet the quality criterion, if they have not already done so. To meet the dementia-friendly environment checklist quality criterion, contractors are required to have completed, on the day of the declaration, a specified dementia-friendly environment checklist and have...

  • Class 4 MHRA drug alert – Xonvea 10 mg/10 mg gastro-resistant tablets (Alliance Pharmaceuticals Limited)
    Wednesday, October 16, 2019 3:29 pm

    Class 4 MHRA drug alert – Xonvea 10 mg/10 mg gastro-resistant tablets (Alliance Pharmaceuticals Limited) Drug alert number: EL (19)A/26 Date issued: 16 October 2019 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 4 pharmacy level caution in use for: Xonvea 10 mg/10 mg gastro-resistant tablets (Alliance Pharmaceuticals Limited) Alliance Pharmaceuticals...

  • PQS: Directory of Services (DoS) update
    Wednesday, October 16, 2019 11:04 am

    We have been made aware that, due to the NHS Urgent Medicine Supply Advanced Service (NUMSAS) and the Digital Minor Illness Referral Service (DMIRS) finishing on 28th October 2019 and the Community Pharmacist Consultation Service (CPCS) starting on 29th October 2019, that this has caused some confusion for community pharmacy contractors when updating their DoS...

  • Contractor Notice: Class 4 Drug Alert For Information / Action Rifadin (Rifampicin) 150mg Capsules
    Wednesday, October 16, 2019 10:27 am

    Class 4 MHRA drug alert – Rifadin (rifampicin) 150mg Capsules (Aventis Pharma Limited t/a Sanofi) Drug alert number: EL (19)A/25 Date issued: 16 October 2019 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 4 pharmacy level caution in use for: Rifadin (rifampicin) 150mg Capsules – PL 04425/5915R Aventis Pharma Limited t/a...

  • Supply Disruption Alert – Ranitidine all oral formulations
    Tuesday, October 15, 2019 5:04 pm

    All oral formulations of Ranitidine are anticipated to be out of stock, with no date for resupply until further notice. The following oral presentations of Ranitidine are affected: Ranitidine 75mg, 150mg and 300mg tablets Ranitidine 150mg and 300mg effervescent tablets Ranitidine 150mg/5ml oral solution Ranitidine 75mg/5ml oral solution The Supply Disruption Alert (SDA/2019/005) issued by DHSC...

  • PSNC responds to government consultation on prevention
    Tuesday, October 15, 2019 4:31 pm

    PSNC has outlined how community pharmacies can contribute to the prevention agenda in its response to a government consultation. Earlier this year, the Government set out a green paper, Advancing our health: prevention in the 2020s, outlining policy ideas to help prevent ill-health. The paper then opened to consultation in the form of an online...

  • Contractor Notice: SSP Endorsement Errors
    Monday, October 14, 2019 3:26 pm

    Following the announcement of the first Serious Shortage Protocols (SSPs) issued on 3rd October 2019 for Fluoxetine capsules, PSNC has been working with NHS Business Services Authority (NHSBSA) to understand if claims are being submitted in accordance with SSP endorsement guidance. During the month of October, NHSBSA has received a number of EPS messages which...

  • Self Care Week 2019
    Monday, October 14, 2019 9:05 am

    Self Care Week, which is an annual national awareness week that focuses on providing support for self care across communities and families, will be running again this year on 18-24th November 2019. The campaign aims to provide people-facing organisations such as community pharmacies with a focus to hold a targeted campaign to support people to take care...

MHRA Regulatory News
VMD Regulatory News
Global Pharmaceutical News

LOCATION

Unit 2 Fleet Business Park, Sandy Lane, Church Crookham, Fleet, Hampshire, GU52 8BF

INFORMATION

Pharmaceutical and Veterinary Licensed Distributor. WDA (H) 43703 & WDA (V) 43703.

CONTACT US

- +44 (0)1252 260 460.
- +44 (0)1276 469 290

OUR OPENING TIMES

Monday to Friday - 09:30 – 18:30
Saturday & Sunday - Closed, Online Ordering Available